The Toll-like receptor family recognizes mostly exogenous ligands like bacterial lipopolysaccharides or DNA and activates the inflammatory cell. Evidence is accumulating that these Toll-like receptors are important in cardiovascular pathologies. Recently, expression of Toll-like receptors in arterial and myocardial cells has been shown and mouse knockout and human studies on polymorphisms point to a role of Toll-like receptor 4 in neointima formation and atherosclerosis. It is now becoming clear that these receptors not only serve as receptors for pathogen-associated molecular patterns but are also involved in the initiation and progression of cardiovascular pathologies.
effector cell of innate immunity, secretes cytokines that dendritic cells [24] . TLR 6 is expressed in thymus, ovary guide and regulate function of other cells that are associand lung and plays a role in enhancement of TLR2 ated with atherogenesis and progression of atherosclerotic function by dimerization. TLRs 7, 8 and 9 are expressed in disease.
different tissues like lung and spleen. Hemmi et al. The receptors that are capable of recognition of PAMPs described that TLR 9 also identifies bacterial DNA [25] . are scavenger receptors and TLRs. In general, the The observation that multiple TLRs are functional in the scavenger receptor has the function of capturing physically recognition and phagocytosis of bacterial epitopes support larger particles as compared to TLRs. The scavenger the idea that these receptors act in concert to elicit an receptors may remove PAMPs from the blood without appropriate immune response. Engagement of TLRs transtriggering inflammatory cellular responses [12] . Macromits transmembrane signals that activate NK-kB and phage scavenger receptor class A recognizes not only mitogen-activated protein kinase (MAPK) pathways bacterial ligands like lipopolysaccharide (LPS) and [5, 6, 26] . Subsequently, TLR ligation induces expression of lipoteichoic acid (LTA) but also oxidized LDL. Scavenger a wide variety of genes like genes encoding proteins receptor A knockout mice show inhibition of atheroscleroinvolved in cytokine production (for TLR4 see Fig. 1 ), sis formation and enhanced susceptibility to infection, leucocyte recruitment and phagocytosis [26, 27] . supporting the role of these receptors in atherosclerotic lesion development [13] .
2 .2. TLR2 and TLR4
.1. Toll like receptors
Although research on the role of TLRs in immunological response still is in its infancy, TLRs 2 and 4 have been The Toll gene was first discovered as encoding for a studied most extensively. Also with respect to cardiovascureceptor responsible for the dorsal ventral pattern in lar disease most research has been focussed on these TLRs. Drosophila embryos. Expression of the TLRs is very TLR2 plays an important role in the innate recognition ubiquitous throughout species like mammals, fruit flies, of ligands associated with Gram-positive bacteria. Cells nematode, chicken and plants [14] . The evolutionary that are reported to express TLR2 are macrophages, conversation of Toll-Like receptors (TLRs) suggests that neutrophils and dendritic cells. Ligands recognized by this class of receptors was involved in establishing im-TLR2 are peptidoglycan, lipoteichoic acid and soluble munity to bacterial infection. The history of research on modulin (Table 1 ) [28] [29] [30] [31] [32] [33] . Also yeast is recognized by the role of the TLRs in immunity is short. In 1997, TLR2. The broad ligand specificity attributed by TLR2 Medzhitov et al. showed that the human homologue of the may be accounted for by the fact that TLR2 must dimerize Drosophila Toll protein is able to initiate an adaptive with other TLRs (like TLR6) to optimally detect these immune response [15] . Just 1 year later the TLR4 was ligands preceding cellular signaling. identified as the gene encoding the LPS receptor which is TLR4 is well known as the LPS receptor. LPS is the not functional in LPS insensitive mice [16, 17] . The history best-characterized ligand for TLR4. However, not only of research on TLRs in cardiovascular disease is even exogenous but also endogenous ligands may bind to TLR4 more recent: just 2 years ago, the first papers were and activate the innate immune response (Table 1) . At published describing the expression of TLRs in atherosfirst, CD14 was thought to be the primary receptor for clerotic plaques [18, 19] . TLRs are type I transmembrane LPS. Indeed, CD14 knockout mice show a decreased receptors with extracellular leucine repeats and a carboxy sensitivity for LPS in vivo and antibodies against CD14 terminal intracellular tail containing a conserved region may block LPS signaling [34, 35] . However, the function called Toll / interleukin1 receptor (TIR) homology domain.
of CD14 is to increase the signaling sensitivity for LPS by The extracellular domain is involved in ligand binding but the TLR4. Other cofactors that enhance LPS / TLR4 signal is also necessary for dimerization [20] . A number of transduction are LPS-binding protein and a new LPSligands have been identified through in vitro systems or interacting protein, MD-2, which is able to evoke a cellular knock-out mice ( Table 1) . Most of these ligands can be response upon LPS addition in a TLR4-dependent manner classified as PAMPs. However, recent evidence suggests [36, 37] . that TLR4 also responds to endogenous factors produced Activation of TLRs 2 and 4 induces NF-kB-dependent by stress or cell damaging, like heat shock proteins [21] , expression of cytokines and chemokines that are known for extracellular matrix components of fibronectin [22] and their roles in leucocyte recruitment and subsequent inhyaluronan [23] .
flammatory responses and hence, atherogenesis. Currently, 10 mammalian TLRs have been discovered. In relation to sepsis, Tlrs 2 and 4 expression have also Expression of these receptors has been found in most been studied in endothelial cells. Compared to carcardiovascular cells (for human expression see Table 2) diomyocytes, endothelial cells have about a 5-fold higher like cardiomyocytes [39] , endothelial cells [6] , adventitial Tlr4 expression [39] . Human endothelial cells express fibroblasts [40] , macrophages [41] and dendritic cells [42] .
predominantly Tlr4 and very low levels of Tlr2 [6] For these cells, studies have been focussed on the role of indicating that Tlr4 might be a potential target for treattoll-like receptor 2 and 4. ment of sepsis and endotoxic shock. LPS and IFN-g induce a 2-fold increase in Tlr2 and Tlr4 expression in endothelial cells [45] . This is in contrast with 3 .1. Myocytes non-vascular gingival fibroblasts which show a small decrease (|20%) in Tlr4 expression after LPS stimulation In neonatal rat cardiomyocytes Tlr2, Tlr3, Tlr4 and Tlr6 [46] . are expressed and Tlr2 is involved in NK-kB activation by oxidative stress suggesting a pro-apoptotic role for Tlr2 3 .3. Adventitial fibroblast and macrophage [39] . Murine Tlr4 expression increases after myocardial infarction and is located in cardiomyocytes adjacent to the The adventitial fibroblast has been recently described as site of ischemic injury and is also found in human an immunologically active cell and is completely equipped idiopathic dilated cardiomyopathy suggesting that Tlr4 is to detect Tlr4 ligands and to respond on Tlr4 activation. involved in a tissue response to injury [39] . Tlr4 also Tlr4 signaling in these cells leads to NK-kB activation and seems to play a role in sepsis-induced myocardial dysfuncproduction of cytokines [40] . However, Tlr4 expression in tion. LPS injection in Tlr4 deficient and control mice these cells did not differ after LPS stimulation (Fig. 2 ). resulted in a significant depression of injection phase This identifies the adventitial fibroblast as a potential indexes of contractile function in the wild-type mouse but key-site for cytokine production leading to an active not in the Tlr4 deficient mouse [43, 44] .
inflammatory process [40] . Relative TLR4 protein expression in human adventitial fibroblasts after 6, 12 and 24 h. stimulation with 100 ng / ml LPS compared to unstimulated adventitial fibroblasts (0 h). Isolation of human adventitial fibroblasts and TLR4 Western blotting was performed as described earlier [40] . n55 / timepoint, data are mean6standard deviation.
After stimulation with LPS, macrophages show a temporary decrease in Tlr4 mRNA expression but return at 24 h LPS treatment to normal Tlr4 mRNA levels as that of non-treated cells [47] . This points to a cell-specific regulation of Tlr4 expression after LPS treatment with an increase in mRNA levels in endothelial cells and a timedependent decrease or constant Tlr4 mRNA levels in fibroblast and macrophages.
.4. Dendritic cells and vascular-associated lymphoid tissue (VALT)
In human peripheral blood, monocytes preferentially express TLRs 1, 2, 4, 5 and 8 while immature dendritic cells express high levels of TLRs 1, 2 and 3 and plas- clerotic lesions [50] and are most dense in regions subjected to turbulent flow conditions [51, 52] . It remains unclear In the healthy and atherosclerotic artery Tlrs1-9 are if the vascular dendritic cell is a different subset of expressed. Double staining indicated that Tlrs 2 and 4 were dendritic cells with its specific toll-like receptor expression primarily expressed in endothelial cells and macrophages pattern. in the atherosclerotic lesions [19, 18] . Although numbers Dendritic cells can form together with immunoare small, expression of Tlr4 in human macrophages seems competent cells the vascular-associated lymphoid tissue to be stimulated with Ox-LDL in contrast to Tlr2 [19] .
(VALT) [53] . VALT is described in the non-diseased arterial wall in the subendothelial layer and around the vaso vasorum in the adventitia and is probably involved in immune response [57]; however, a role for TLRs in these 1) to a C3H host revealed no differences in artherosadventitial infiltrates is unknown.
clerotic lesion formation which points to an important role of the arterial wall cells in artherosclerosis [70] . Perhaps, arterial wall cells of the C3H mouse are unable to recruit 4 . Toll-like receptors and atherosclerosis monocytes into the arterial wall which would explain the low number of macrophages in C3H artherosclerotic It is established that atherosclerosis is a complex process lesions, compared to B6 lesions. with immunological responses at the initiation and proAlthough the C3H mouse does not respond to exogengression of this occlusive disease. Atherosclerosis is now ous LPS and endogenous EDA [22] due to a TLR4 point considered an inflammatory disease [58, 59] . Inflammatory mutation, strain differences are based on more genes then cells, like monocyte derived macrophages and T-lymphothe TLR4 gene. Therefore, it is not possible to relate strain cytes, are observed at all stages of atherosclerosis [60, 61] .
differences in atherosclerotic susceptibility with one muThe arterial inflammatory reaction stimulates proliferation tated TLR4 receptor. TLR2, TLR4 and TLR9 knockout and migration of smooth muscle cells that become intermice exist [71] and open the possibility to study the mixed with the area of inflammation. Continuous inflamimportance of these receptors in different controlled backmation and the formation of fibrous tissue lead to further grounds including atherosclerotic backgrounds like progression and enlargement of the lesion. The presence of ApoE(2 / 2) and ApoE3 Leiden. local plaque rupture is associated with the presence of The C3H Tlr4 point mutation in a Balb / C background is inflammatory cells that are capable of producing and already commercially (Jackson Lab, www.jax.org) availsecreting matrix-degrading enzymes and aggravate the able. Using a femoral cuff model in these mice showed recruitment of additional inflammatory cells and productthat after adventitial LPS stimulation, neointima formation ion of chemokines and cytokines [62, 63] .
was reduced by 60% in the TLR4 deficient mouse. This Since TLRs can initiate the innate and sequentially the demonstrates that adventitial activation of TLR4 leads to adaptive immune system, both responsible for inflammaaugmentation of neointima formation [40] which is considtion, one can assume that TLRs play a role in this process.
ered the 'soil' of atherosclerosis [72] . Especially Tlr4 is interesting, since this receptor has also endogenous ligands like Hsp60 and alternatively spliced 4 .2. Human studies fibronectin EDA domain [64] .
Several descriptive studies show that TLRs and TLR 4 .1. The rat and mouse as a model ligands are present in the human atherosclerotic plaque [18, 19] and adventitia [40] pointing to a role of innate Although at that time the LPS receptor TLR4 was immunity in atherosclerosis. unknown, it was found that after adventitial LPS applicaUntil now, only Kiechl et al. [73] showed that a tion on the rat femoral artery resulted in intimal lesion Asp299Gly TLR4 polymorphism which attenuates receptor formation [65] and was the first association between signaling is associated with a lower risk of carotid arbacterial antigen and neointima formation.
therosclerosis. These data provide for the first time epiStudies on different strains of inbred mice for their demiological evidence for the concept that TLR4 is susceptibility for atherosclerosis showed that there are involved in the development of atherosclerosis. considerable differences between the strains. The natural TLR4-deficient strain C3H / HeJ (C3H) which is insensi-4 .3. Matrix turn-over and Toll-like receptors tive to LPS, is one of the strains that are less susceptible to diet-induced atherosclerosis [66, 67] . Based on this, C3H
Several studies show that Toll-like receptor 4 is associApoE(2 / 2) mice and C57Bl ApoE(2 / 2) were compared ated with matrix turn-over. In monocytes, activation of in atherosclerotic lesion formation and showed more TLR4 by LPS increased the production of matrix metalloatherosclerotic lesions in the C57Bl ApoE(2 / 2) despite protease 9 (MMP-9) [22] , whereas in cervical smooth the lower plasma lipid concentrations [68] . Atherosclerosis muscle cells LPS application increased mRNA levels can develop without pathogens [69] supporting a role for encoding MMP-1, MMP-3 and the elastase cathepsin S the endogenous ligands of TLR4 [64] in atherosclerosis. [74] . Furthermore, the endogenous Tlr4 ligands, Hsp 60 This study [69] seems to be in contradiction with Grimand EDA, have been observed in arthritic [75] and ditch et al. [68] , since they show that cholesterol ether oncological specimens [76, 77] in which matrix turn-over is levels in the aorta did not differ between ApoE(2 / 2) and an important feature while the TLR2 ligand peptidoglycan ApoE(2 / 2) LPS-deficient mice. Unfortunately, atheroshas been associated with an unstable plaque phenotype clerotic lesion size was not measured in these two groups [78] . This point to a role of TLR2 and 4 in matrix [69] which is generally accepted as the standard for turn-over. Matrix turn-over and inflammation are two atherosclerosis.
important processes in the progression of atherosclerosis Bone marrow transplantation of ApoE(2 / 2) or Apo(1 / but also in other cardiovascular diseases (Fig. 3) . 
. A possible role of the adventitial fibroblast in
finding that adventitial fibroblasts contribute to neointimal plaque and neointima formation?
formation [81, 82] . Furthermore, adventitial LPS application resulted in neointima formation [40, 65] in which Recent studies have led to the concept that fibroblasts TLR4 is involved [40] . are key-sites of cytokine synthesis which can initiate
In atherosclerotic arteries, adventitial inflammation has inflammatory processes [79] .
been associated with clinical manifest atherosclerotic Moreover, LPS stimulation of mouse embryonic fibrolesions [83] . Similarly, the presence of C pneumonia blasts increased cell migration [80] pointing to a role of staining in the adventitia was associated with the amount TLR4 in fibroblast migration. This is in agreement with the of local atherosclerotic plaque [84] . This suggests that inflammation in the adventitia might play a role in luminal plaque / neointima formation. Fibroblasts are the most prominent adventitial cells in the healthy artery. In healthy pig and rabbit arteries, we could not detect any macrophages (results not shown). Since the adventitial fibroblast contains a functional TLR4 pathway [40] it might be possible that activation of adventitial TLR4 on one hand initiates adventitial inflammation by attracting monocytes via cytokine secretion and on the other hand stimulates migration of adventitial fibroblasts and medial smooth muscle cells to form the neointima (Fig. 4) . This does not exclude the luminal contribution via the luminal endothelial cell or the contribution of lipids but adds another possible pathway in the origin of atherosclerosis and neointima formation.
. TLRs, tolerance and cross-tolerance
The immune system is capable of suppressing the inflammatory response to endogenous and exogenous ligands. Specifically in the case of autoantigens, the inflammatory response is damaging and causally related with the clinical presentation of the auto-immune disease. Thus, downtuning the immune response against atherosclerosis related antigens may theoretically impair the progression of this occlusive disease.
Human TLR4 recognizes LPS. Prolonged exposure of human macrophages or monocytes to bacterial LPS in- [85,86]. In addition, tolerance is also observed for the 7 . TLRs and ligands: targets for intervention? TLR2 ligand lipotheichoic acid after LPS stimulation (via TLR4) and for the TLR4 ligand LPS after lipotheichoic
In vitro and in vivo mice knockout studies suggest that acid (via Tlr2) showing that LPS-stimulated monocytes are TLRs are crucial players in atherosclerotic lesion and less susceptible to respond to the TLR2 ligand lipoteichoic intimal hyperplasia formation by modulating the inflammaacid, as well as that lipoteichoic acid-stimulated monocytes tory response upon exogenous and endogenous triggering. respond less to subsequent LPS stimulation [87] . Taken Studies in C3H mice lacking a functional TLR4 strongly together, these observations indicate the existence of a indicate that inhibition of TLR4 function impairs the feedback mechanism that inhibits excessive TLR ligand inflammatory response and thereby intima formation. In responses in monocytes. The mechanism of antigen-inaddition, recently it was discovered that a nucleotide duced tolerance is not fully understood. In vitro data on polymorphism in the TLR4 gene, Asp299Gly and TLR expression reveal that (over) expression of TLR2 or Thr399Ile, are associated with reduced extent and pro-TLR4 is not associated with the development of crossgression of carotid atherosclerosis as quantified by B-mode tolerance [86] . Moreover, LPS and lipoteichoic acid-inultrasound [73] . These observations make the TLR a novel duced tolerance seem to have distinct mechanisms in the potential target to consider for intervention in these sense that unique TLR2 signaling components are disprocesses. However, since functional TLRs are obligatory rupted when TLR2 lipoteichoic acid tolerance develops for a normal response to bacterial infiltration and control of [85] . Tolerance induction is also not caused by paracrine innate, and subsequently adaptive, immunity it might be factors [87] . In the search for the mechanisms that are complicated when TLRs are down regulated systemically. responsible for ligand tolerance it has also been described This concept is supported by observations that TLRs and that surgical interventions induce endotoxin tolerance [88] , CD14 knock out mice suffer from increased prevalence of indicating that endogenous stress-induced ligands may bacterial infections. Two options to affect the inflammatrigger ligand tolerance.
tory response to TLR-ligand binding could be considered: The TLRs also have interacting binding partners in vivo local treatment with a TLR inhibitor or ligand immunizathat may help to understand the tolerance development for tion. TLR ligands. For LPS, two well-characterized interacting molecules are lipopolysaccharide binding protein (LBP) 7 .1. Local treatment and CD14. In vitro, the blood of LBP knockout mice is hyporesponsive to LPS [89] suggesting that this protein is Except for antibodies that inhibit TLR function, an critical to exert its inflammatory potential. However, in analogue or inhibitor of TLRs has not been described yet. vivo LBP knockout mice only reveal slight hyporesponThis makes it difficult to speculate upon the effect of siveness to LPS [89] . Conflicting with these observations systemically blocking the TLR receptor function in vivo. is the finding that high concentrations of LBP in serum of Assuming that the TLR knock out mice studies can be patients with severe sepsis inhibit the LPS response in extrapolated to pharmaceutical interventions in human human monocytes [90] . Literature on the role of CD14 in beings, then it is not likely that TLR-blockers could be tolerance development seems to hide contradictions that developed for long term systemic treatment. Local drug can be explained by the differential roles of cell bound delivery, however, would theoretically be feasible. Drug CD14 and soluble CD14. On one hand, trials with CD14 eluding stents encompassing a TLR4 inhibitor might have antibodies revealed a protection against LPS-induced beneficial effects on the development of in stent restenosis. toxicity in rabbits and monkeys [91] . This is confirmed in This hypothesis is supported by the observations that in human studies in which CD14 antibodies are able to inhibit stent restenosis seems to be driven by the inflammatory LPS-induced effects like cytokine release and clinical response and that TLR4-deficient mice develop less neoinsymptoms. On the other hand, soluble CD14 decreases tima formation [40] . Atherosclerotic lesions that contain monocyte responses to LPS by transferring cell-bound LPS large numbers of inflammatory cells and hide large to plasma proteins with subsequent significant reduction in atheromas could stabilize when local recruitment of macrothe ability of monocytes to produce cytokines in response phages is impaired by blocking the TLR receptor therefore to LPS. The recently described soluble form of TLR4 [92] subsequently decreasing cytokine and chemokine release. shares this capability to inhibit excessive LPS responses.
The recent developments in visualization of these potenIn mouse macrophages, expression of the alternatively tially rupture prone lesions might help selecting and spliced soluble TLR4 is enhanced after LPS stimulation. is a chaperone that protects proteins during maturation and ligand for TLR2 and present in inflammatory plaques [78] , 
